nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—kidney cancer—lung cancer	0.228	1	CtDrD
Sunitinib—DAPK1—lung cancer	0.0403	0.154	CbGaD
Sunitinib—STK11—lung cancer	0.0353	0.135	CbGaD
Sunitinib—AXL—lung cancer	0.0334	0.128	CbGaD
Sunitinib—MAP2K1—lung cancer	0.0284	0.109	CbGaD
Sunitinib—FGR—lung cancer	0.0284	0.109	CbGaD
Sunitinib—FGFR1—lung cancer	0.0212	0.081	CbGaD
Sunitinib—FLT1—lung cancer	0.0203	0.0774	CbGaD
Sunitinib—ALK—lung cancer	0.0203	0.0774	CbGaD
Sunitinib—SBK1—Gefitinib—lung cancer	0.0162	0.0502	CbGbCtD
Sunitinib—KDR—lung cancer	0.0127	0.0485	CbGaD
Sunitinib—KIT—lung cancer	0.012	0.0458	CbGaD
Sunitinib—CSNK1E—Gefitinib—lung cancer	0.0117	0.0363	CbGbCtD
Sunitinib—CHEK2—Gefitinib—lung cancer	0.0117	0.0363	CbGbCtD
Sunitinib—LOC400927-CSNK1E—Gefitinib—lung cancer	0.0117	0.0363	CbGbCtD
Sunitinib—IRAK4—Gefitinib—lung cancer	0.00933	0.0288	CbGbCtD
Sunitinib—TNK1—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—MAP4K2—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—RPS6KB1—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—TYK2—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—STK4—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—MERTK—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—MAP3K12—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—STK3—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—TBK1—Crizotinib—lung cancer	0.0072	0.0222	CbGbCtD
Sunitinib—TNK1—Erlotinib—lung cancer	0.00695	0.0215	CbGbCtD
Sunitinib—ULK3—Erlotinib—lung cancer	0.00695	0.0215	CbGbCtD
Sunitinib—IRAK1—Gefitinib—lung cancer	0.00675	0.0208	CbGbCtD
Sunitinib—ABCG2—lung cancer	0.00663	0.0254	CbGaD
Sunitinib—HIPK4—Gefitinib—lung cancer	0.00596	0.0184	CbGbCtD
Sunitinib—PTK2B—Crizotinib—lung cancer	0.00572	0.0177	CbGbCtD
Sunitinib—JAK2—Crizotinib—lung cancer	0.00572	0.0177	CbGbCtD
Sunitinib—ALK—Crizotinib—lung cancer	0.00572	0.0177	CbGbCtD
Sunitinib—MAP4K1—Crizotinib—lung cancer	0.00572	0.0177	CbGbCtD
Sunitinib—AXL—Crizotinib—lung cancer	0.00572	0.0177	CbGbCtD
Sunitinib—TYRO3—Crizotinib—lung cancer	0.00572	0.0177	CbGbCtD
Sunitinib—NUAK2—Crizotinib—lung cancer	0.00572	0.0177	CbGbCtD
Sunitinib—BMP2K—Crizotinib—lung cancer	0.00572	0.0177	CbGbCtD
Sunitinib—AURKC—Erlotinib—lung cancer	0.00552	0.017	CbGbCtD
Sunitinib—STK10—Gefitinib—lung cancer	0.00536	0.0166	CbGbCtD
Sunitinib—MAP2K5—Gefitinib—lung cancer	0.00488	0.0151	CbGbCtD
Sunitinib—YES1—Crizotinib—lung cancer	0.00479	0.0148	CbGbCtD
Sunitinib—SLK—Crizotinib—lung cancer	0.00479	0.0148	CbGbCtD
Sunitinib—PLK4—Crizotinib—lung cancer	0.00479	0.0148	CbGbCtD
Sunitinib—MAP3K3—Crizotinib—lung cancer	0.00479	0.0148	CbGbCtD
Sunitinib—MAP4K5—Crizotinib—lung cancer	0.00479	0.0148	CbGbCtD
Sunitinib—TAOK3—Crizotinib—lung cancer	0.00479	0.0148	CbGbCtD
Sunitinib—NTRK1—Crizotinib—lung cancer	0.00479	0.0148	CbGbCtD
Sunitinib—SLK—Erlotinib—lung cancer	0.00462	0.0143	CbGbCtD
Sunitinib—MAP3K19—Gefitinib—lung cancer	0.00448	0.0139	CbGbCtD
Sunitinib—MAP3K2—Crizotinib—lung cancer	0.00414	0.0128	CbGbCtD
Sunitinib—FLT3—Crizotinib—lung cancer	0.00414	0.0128	CbGbCtD
Sunitinib—FGR—Crizotinib—lung cancer	0.00414	0.0128	CbGbCtD
Sunitinib—IRAK1—Crizotinib—lung cancer	0.00414	0.0128	CbGbCtD
Sunitinib—FLT3—Erlotinib—lung cancer	0.00399	0.0123	CbGbCtD
Sunitinib—EPHB6—Crizotinib—lung cancer	0.00366	0.0113	CbGbCtD
Sunitinib—BLK—Crizotinib—lung cancer	0.00366	0.0113	CbGbCtD
Sunitinib—HIPK4—Erlotinib—lung cancer	0.00353	0.0109	CbGbCtD
Sunitinib—STK10—Crizotinib—lung cancer	0.00329	0.0102	CbGbCtD
Sunitinib—CSF1R—Crizotinib—lung cancer	0.00329	0.0102	CbGbCtD
Sunitinib—STK10—Erlotinib—lung cancer	0.00317	0.00979	CbGbCtD
Sunitinib—MAP2K5—Erlotinib—lung cancer	0.00288	0.00891	CbGbCtD
Sunitinib—ABCB1—lung cancer	0.00276	0.0106	CbGaD
Sunitinib—MAP3K19—Crizotinib—lung cancer	0.00275	0.00849	CbGbCtD
Sunitinib—MAP3K19—Erlotinib—lung cancer	0.00265	0.00819	CbGbCtD
Sunitinib—ABCG2—Topotecan—lung cancer	0.000968	0.00299	CbGbCtD
Sunitinib—ABCG2—Gefitinib—lung cancer	0.000885	0.00273	CbGbCtD
Sunitinib—ABCG2—Teniposide—lung cancer	0.000858	0.00265	CbGbCtD
Sunitinib—ABCC2—Paclitaxel—lung cancer	0.00053	0.00164	CbGbCtD
Sunitinib—ABCG2—Erlotinib—lung cancer	0.000523	0.00162	CbGbCtD
Sunitinib—ABCC2—Irinotecan—lung cancer	0.000523	0.00162	CbGbCtD
Sunitinib—CYP3A5—Gefitinib—lung cancer	0.00049	0.00152	CbGbCtD
Sunitinib—ABCG2—Paclitaxel—lung cancer	0.000479	0.00148	CbGbCtD
Sunitinib—CYP3A5—Teniposide—lung cancer	0.000476	0.00147	CbGbCtD
Sunitinib—ABCG2—Irinotecan—lung cancer	0.000473	0.00146	CbGbCtD
Sunitinib—ABCC4—Methotrexate—lung cancer	0.000465	0.00144	CbGbCtD
Sunitinib—ABCC2—Vinblastine—lung cancer	0.000465	0.00144	CbGbCtD
Sunitinib—ABCC2—Cisplatin—lung cancer	0.000426	0.00132	CbGbCtD
Sunitinib—ABCC2—Etoposide—lung cancer	0.000419	0.00129	CbGbCtD
Sunitinib—ABCG2—Cisplatin—lung cancer	0.000385	0.00119	CbGbCtD
Sunitinib—ABCC2—Docetaxel—lung cancer	0.000383	0.00118	CbGbCtD
Sunitinib—ABCG2—Etoposide—lung cancer	0.000379	0.00117	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.000354	0.00109	CbGbCtD
Sunitinib—CYP3A7—Paclitaxel—lung cancer	0.000354	0.00109	CbGbCtD
Sunitinib—CYP3A7—Irinotecan—lung cancer	0.000349	0.00108	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.000349	0.00108	CbGbCtD
Sunitinib—ABCB1—Topotecan—lung cancer	0.000349	0.00108	CbGbCtD
Sunitinib—ABCG2—Docetaxel—lung cancer	0.000346	0.00107	CbGbCtD
Sunitinib—ABCB1—Gefitinib—lung cancer	0.000319	0.000986	CbGbCtD
Sunitinib—CYP3A5—Crizotinib—lung cancer	0.000301	0.000929	CbGbCtD
Sunitinib—CYP3A5—Erlotinib—lung cancer	0.00029	0.000896	CbGbCtD
Sunitinib—ABCC2—Doxorubicin—lung cancer	0.000286	0.000882	CbGbCtD
Sunitinib—ABCC2—Methotrexate—lung cancer	0.000277	0.000855	CbGbCtD
Sunitinib—CYP3A5—Paclitaxel—lung cancer	0.000265	0.00082	CbGbCtD
Sunitinib—CYP3A5—Irinotecan—lung cancer	0.000262	0.000809	CbGbCtD
Sunitinib—ABCG2—Doxorubicin—lung cancer	0.000258	0.000798	CbGbCtD
Sunitinib—CYP3A7—Docetaxel—lung cancer	0.000256	0.00079	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.000256	0.00079	CbGbCtD
Sunitinib—ABCG2—Methotrexate—lung cancer	0.00025	0.000773	CbGbCtD
Sunitinib—ABCB1—Vinorelbine—lung cancer	0.000246	0.00076	CbGbCtD
Sunitinib—ROCK1—Irinotecan—Topotecan—lung cancer	0.000223	0.154	CbGdCrCtD
Sunitinib—CYP3A5—Etoposide—lung cancer	0.00021	0.000648	CbGbCtD
Sunitinib—CYP3A4—Topotecan—lung cancer	0.000209	0.000646	CbGbCtD
Sunitinib—MAP4K4—Irinotecan—Topotecan—lung cancer	0.000199	0.138	CbGdCrCtD
Sunitinib—ABCB1—Crizotinib—lung cancer	0.000196	0.000604	CbGbCtD
Sunitinib—CYP3A5—Docetaxel—lung cancer	0.000192	0.000593	CbGbCtD
Sunitinib—CYP3A4—Gefitinib—lung cancer	0.000191	0.000591	CbGbCtD
Sunitinib—ABCB1—Gemcitabine—lung cancer	0.000191	0.000591	CbGbCtD
Sunitinib—ABCB1—Erlotinib—lung cancer	0.000189	0.000583	CbGbCtD
Sunitinib—CYP3A4—Teniposide—lung cancer	0.000185	0.000573	CbGbCtD
Sunitinib—ABCB1—Paclitaxel—lung cancer	0.000173	0.000534	CbGbCtD
Sunitinib—ABCB1—Irinotecan—lung cancer	0.00017	0.000527	CbGbCtD
Sunitinib—TLK2—Irinotecan—Topotecan—lung cancer	0.000169	0.117	CbGdCrCtD
Sunitinib—ABCB1—Vinblastine—lung cancer	0.000152	0.000468	CbGbCtD
Sunitinib—CYP3A4—Vinorelbine—lung cancer	0.000147	0.000455	CbGbCtD
Sunitinib—ABCB1—Cisplatin—lung cancer	0.000139	0.000429	CbGbCtD
Sunitinib—ABCB1—Etoposide—lung cancer	0.000136	0.000422	CbGbCtD
Sunitinib—ABCB1—Docetaxel—lung cancer	0.000125	0.000386	CbGbCtD
Sunitinib—CYP3A4—Crizotinib—lung cancer	0.000117	0.000362	CbGbCtD
Sunitinib—CYP3A4—Erlotinib—lung cancer	0.000113	0.000349	CbGbCtD
Sunitinib—CYP3A4—Paclitaxel—lung cancer	0.000104	0.00032	CbGbCtD
Sunitinib—CYP3A4—Irinotecan—lung cancer	0.000102	0.000315	CbGbCtD
Sunitinib—ABCB1—Doxorubicin—lung cancer	9.31e-05	0.000288	CbGbCtD
Sunitinib—CYP3A4—Vinblastine—lung cancer	9.08e-05	0.00028	CbGbCtD
Sunitinib—ABCB1—Methotrexate—lung cancer	9.02e-05	0.000279	CbGbCtD
Sunitinib—OXSR1—Afatinib—Gefitinib—lung cancer	8.19e-05	0.0568	CbGdCrCtD
Sunitinib—CYP3A4—Etoposide—lung cancer	8.18e-05	0.000253	CbGbCtD
Sunitinib—DYRK1A—Topotecan—Irinotecan—lung cancer	7.69e-05	0.0533	CbGdCrCtD
Sunitinib—CYP3A4—Docetaxel—lung cancer	7.48e-05	0.000231	CbGbCtD
Sunitinib—STK24—Teniposide—Etoposide—lung cancer	7.44e-05	0.0516	CbGdCrCtD
Sunitinib—CHEK2—Docetaxel—Paclitaxel—lung cancer	6.51e-05	0.0451	CbGdCrCtD
Sunitinib—MAP2K2—cardiac atrium—lung cancer	6.41e-05	0.00144	CbGeAlD
Sunitinib—ULK3—cardiac atrium—lung cancer	6.41e-05	0.00144	CbGeAlD
Sunitinib—KDR—respiratory system—lung cancer	6.39e-05	0.00144	CbGeAlD
Sunitinib—CLK4—lymph node—lung cancer	6.39e-05	0.00144	CbGeAlD
Sunitinib—RPS6KB1—trachea—lung cancer	6.38e-05	0.00144	CbGeAlD
Sunitinib—MAP4K4—bone marrow—lung cancer	6.37e-05	0.00143	CbGeAlD
Sunitinib—CLK2—lung—lung cancer	6.36e-05	0.00143	CbGeAlD
Sunitinib—MAP4K2—lung—lung cancer	6.34e-05	0.00143	CbGeAlD
Sunitinib—NUAK2—bone marrow—lung cancer	6.32e-05	0.00142	CbGeAlD
Sunitinib—AXL—trachea—lung cancer	6.32e-05	0.00142	CbGeAlD
Sunitinib—FLT1—epithelium—lung cancer	6.32e-05	0.00142	CbGeAlD
Sunitinib—ITK—lymph node—lung cancer	6.31e-05	0.00142	CbGeAlD
Sunitinib—SBK1—lymph node—lung cancer	6.31e-05	0.00142	CbGeAlD
Sunitinib—MAP3K7—cardiac atrium—lung cancer	6.31e-05	0.00142	CbGeAlD
Sunitinib—FLT3—bone marrow—lung cancer	6.28e-05	0.00141	CbGeAlD
Sunitinib—STK3—lung—lung cancer	6.25e-05	0.00141	CbGeAlD
Sunitinib—CSF1R—respiratory system—lung cancer	6.24e-05	0.00141	CbGeAlD
Sunitinib—BLK—lymph node—lung cancer	6.24e-05	0.0014	CbGeAlD
Sunitinib—TBK1—cardiac atrium—lung cancer	6.23e-05	0.0014	CbGeAlD
Sunitinib—FLT1—bronchus—lung cancer	6.22e-05	0.0014	CbGeAlD
Sunitinib—TYK2—cardiac atrium—lung cancer	6.19e-05	0.00139	CbGeAlD
Sunitinib—RPS6KA3—bone marrow—lung cancer	6.19e-05	0.00139	CbGeAlD
Sunitinib—ROCK1—lung—lung cancer	6.17e-05	0.00139	CbGeAlD
Sunitinib—DAPK1—lymph node—lung cancer	6.17e-05	0.00139	CbGeAlD
Sunitinib—PHKG1—lymph node—lung cancer	6.17e-05	0.00139	CbGeAlD
Sunitinib—EPHB6—bronchus—lung cancer	6.15e-05	0.00139	CbGeAlD
Sunitinib—MAP2K1—bone marrow—lung cancer	6.15e-05	0.00138	CbGeAlD
Sunitinib—SLK—trachea—lung cancer	6.08e-05	0.00137	CbGeAlD
Sunitinib—CSNK1A1—bone marrow—lung cancer	6.07e-05	0.00137	CbGeAlD
Sunitinib—CLK1—bone marrow—lung cancer	6.03e-05	0.00136	CbGeAlD
Sunitinib—DYRK1A—lung—lung cancer	6.02e-05	0.00135	CbGeAlD
Sunitinib—RPS6KB1—cardiac atrium—lung cancer	6e-05	0.00135	CbGeAlD
Sunitinib—JAK2—trachea—lung cancer	6e-05	0.00135	CbGeAlD
Sunitinib—STK11—lymph node—lung cancer	5.97e-05	0.00135	CbGeAlD
Sunitinib—BRD4—lymph node—lung cancer	5.97e-05	0.00135	CbGeAlD
Sunitinib—YES1—bronchus—lung cancer	5.95e-05	0.00134	CbGeAlD
Sunitinib—AXL—cardiac atrium—lung cancer	5.94e-05	0.00134	CbGeAlD
Sunitinib—CAMK2G—bone marrow—lung cancer	5.92e-05	0.00133	CbGeAlD
Sunitinib—BMP2K—bone marrow—lung cancer	5.92e-05	0.00133	CbGeAlD
Sunitinib—FYN—trachea—lung cancer	5.92e-05	0.00133	CbGeAlD
Sunitinib—RIOK1—lymph node—lung cancer	5.91e-05	0.00133	CbGeAlD
Sunitinib—RPS6KA1—lymph node—lung cancer	5.91e-05	0.00133	CbGeAlD
Sunitinib—STK10—bronchus—lung cancer	5.89e-05	0.00133	CbGeAlD
Sunitinib—MERTK—lung—lung cancer	5.88e-05	0.00132	CbGeAlD
Sunitinib—TAOK3—bronchus—lung cancer	5.87e-05	0.00132	CbGeAlD
Sunitinib—LRRK2—bone marrow—lung cancer	5.87e-05	0.00132	CbGeAlD
Sunitinib—MARK2—lymph node—lung cancer	5.8e-05	0.00131	CbGeAlD
Sunitinib—TNIK—lymph node—lung cancer	5.8e-05	0.00131	CbGeAlD
Sunitinib—PRKAA1—bone marrow—lung cancer	5.78e-05	0.0013	CbGeAlD
Sunitinib—MAP3K3—trachea—lung cancer	5.78e-05	0.0013	CbGeAlD
Sunitinib—MAP4K5—trachea—lung cancer	5.78e-05	0.0013	CbGeAlD
Sunitinib—MAP4K4—lung—lung cancer	5.77e-05	0.0013	CbGeAlD
Sunitinib—SGK3—lymph node—lung cancer	5.74e-05	0.00129	CbGeAlD
Sunitinib—NUAK2—lung—lung cancer	5.73e-05	0.00129	CbGeAlD
Sunitinib—PTK2B—bone marrow—lung cancer	5.72e-05	0.00129	CbGeAlD
Sunitinib—SLK—cardiac atrium—lung cancer	5.71e-05	0.00129	CbGeAlD
Sunitinib—FLT4—bone marrow—lung cancer	5.7e-05	0.00128	CbGeAlD
Sunitinib—ICK—lymph node—lung cancer	5.69e-05	0.00128	CbGeAlD
Sunitinib—FLT3—lung—lung cancer	5.69e-05	0.00128	CbGeAlD
Sunitinib—MAP3K12—lung—lung cancer	5.69e-05	0.00128	CbGeAlD
Sunitinib—KIT—respiratory system—lung cancer	5.67e-05	0.00128	CbGeAlD
Sunitinib—JAK2—cardiac atrium—lung cancer	5.63e-05	0.00127	CbGeAlD
Sunitinib—RPS6KA3—lung—lung cancer	5.61e-05	0.00126	CbGeAlD
Sunitinib—FLT1—trachea—lung cancer	5.59e-05	0.00126	CbGeAlD
Sunitinib—CYP3A4—Doxorubicin—lung cancer	5.58e-05	0.000172	CbGbCtD
Sunitinib—MAP2K1—lung—lung cancer	5.57e-05	0.00125	CbGeAlD
Sunitinib—FYN—cardiac atrium—lung cancer	5.56e-05	0.00125	CbGeAlD
Sunitinib—IRAK4—bone marrow—lung cancer	5.54e-05	0.00125	CbGeAlD
Sunitinib—PDGFRB—respiratory system—lung cancer	5.53e-05	0.00125	CbGeAlD
Sunitinib—EPHB6—trachea—lung cancer	5.52e-05	0.00124	CbGeAlD
Sunitinib—CSNK1A1—lung—lung cancer	5.5e-05	0.00124	CbGeAlD
Sunitinib—NUAK1—lymph node—lung cancer	5.5e-05	0.00124	CbGeAlD
Sunitinib—CHEK2—lymph node—lung cancer	5.5e-05	0.00124	CbGeAlD
Sunitinib—CLK1—lung—lung cancer	5.46e-05	0.00123	CbGeAlD
Sunitinib—OXSR1—lymph node—lung cancer	5.45e-05	0.00123	CbGeAlD
Sunitinib—INSR—lymph node—lung cancer	5.45e-05	0.00123	CbGeAlD
Sunitinib—SNRK—lymph node—lung cancer	5.45e-05	0.00123	CbGeAlD
Sunitinib—MAP4K5—cardiac atrium—lung cancer	5.43e-05	0.00122	CbGeAlD
Sunitinib—MAP3K3—cardiac atrium—lung cancer	5.43e-05	0.00122	CbGeAlD
Sunitinib—MAP2K2—bone marrow—lung cancer	5.41e-05	0.00122	CbGeAlD
Sunitinib—ULK3—bone marrow—lung cancer	5.41e-05	0.00122	CbGeAlD
Sunitinib—MAP3K2—bone marrow—lung cancer	5.37e-05	0.00121	CbGeAlD
Sunitinib—RPS6KA2—lymph node—lung cancer	5.36e-05	0.00121	CbGeAlD
Sunitinib—STK38—lymph node—lung cancer	5.36e-05	0.00121	CbGeAlD
Sunitinib—CAMK2G—lung—lung cancer	5.36e-05	0.00121	CbGeAlD
Sunitinib—BMP2K—lung—lung cancer	5.36e-05	0.00121	CbGeAlD
Sunitinib—KDR—epithelium—lung cancer	5.34e-05	0.0012	CbGeAlD
Sunitinib—YES1—trachea—lung cancer	5.34e-05	0.0012	CbGeAlD
Sunitinib—MAP3K7—bone marrow—lung cancer	5.32e-05	0.0012	CbGeAlD
Sunitinib—AURKC—lymph node—lung cancer	5.32e-05	0.0012	CbGeAlD
Sunitinib—LRRK2—lung—lung cancer	5.31e-05	0.0012	CbGeAlD
Sunitinib—CSNK1G2—lymph node—lung cancer	5.28e-05	0.00119	CbGeAlD
Sunitinib—PKN1—lymph node—lung cancer	5.28e-05	0.00119	CbGeAlD
Sunitinib—TAOK3—trachea—lung cancer	5.27e-05	0.00119	CbGeAlD
Sunitinib—TBK1—bone marrow—lung cancer	5.26e-05	0.00119	CbGeAlD
Sunitinib—KDR—bronchus—lung cancer	5.26e-05	0.00118	CbGeAlD
Sunitinib—MAP2K5—bronchus—lung cancer	5.26e-05	0.00118	CbGeAlD
Sunitinib—PLK4—Topotecan—Irinotecan—lung cancer	5.25e-05	0.0364	CbGdCrCtD
Sunitinib—FLT1—cardiac atrium—lung cancer	5.25e-05	0.00118	CbGeAlD
Sunitinib—PRKAA1—lung—lung cancer	5.24e-05	0.00118	CbGeAlD
Sunitinib—PDGFRA—trachea—lung cancer	5.24e-05	0.00118	CbGeAlD
Sunitinib—TYK2—bone marrow—lung cancer	5.23e-05	0.00118	CbGeAlD
Sunitinib—PLK4—Etoposide—Teniposide—lung cancer	5.22e-05	0.0362	CbGdCrCtD
Sunitinib—PRPF4—lymph node—lung cancer	5.21e-05	0.00117	CbGeAlD
Sunitinib—EPHB6—cardiac atrium—lung cancer	5.19e-05	0.00117	CbGeAlD
Sunitinib—PTK2B—lung—lung cancer	5.18e-05	0.00117	CbGeAlD
Sunitinib—FLT4—lung—lung cancer	5.16e-05	0.00116	CbGeAlD
Sunitinib—IRAK1—bone marrow—lung cancer	5.16e-05	0.00116	CbGeAlD
Sunitinib—CSF1R—bronchus—lung cancer	5.13e-05	0.00116	CbGeAlD
Sunitinib—PRPF4B—lymph node—lung cancer	5.13e-05	0.00116	CbGeAlD
Sunitinib—CSNK1E—lung—lung cancer	5.09e-05	0.00115	CbGeAlD
Sunitinib—FGFR1—lung—lung cancer	5.09e-05	0.00115	CbGeAlD
Sunitinib—RPS6KB1—bone marrow—lung cancer	5.06e-05	0.00114	CbGeAlD
Sunitinib—STK39—lymph node—lung cancer	5.06e-05	0.00114	CbGeAlD
Sunitinib—FGR—bone marrow—lung cancer	5.03e-05	0.00113	CbGeAlD
Sunitinib—IRAK4—lung—lung cancer	5.02e-05	0.00113	CbGeAlD
Sunitinib—YES1—cardiac atrium—lung cancer	5.01e-05	0.00113	CbGeAlD
Sunitinib—CSNK2A1—lymph node—lung cancer	4.99e-05	0.00112	CbGeAlD
Sunitinib—TAOK3—cardiac atrium—lung cancer	4.95e-05	0.00111	CbGeAlD
Sunitinib—MYLK—lymph node—lung cancer	4.93e-05	0.00111	CbGeAlD
Sunitinib—MAP2K2—lung—lung cancer	4.9e-05	0.0011	CbGeAlD
Sunitinib—ULK3—lung—lung cancer	4.9e-05	0.0011	CbGeAlD
Sunitinib—MAP3K2—lung—lung cancer	4.87e-05	0.0011	CbGeAlD
Sunitinib—PLK4—lymph node—lung cancer	4.87e-05	0.0011	CbGeAlD
Sunitinib—STK4—lymph node—lung cancer	4.84e-05	0.00109	CbGeAlD
Sunitinib—SLK—bone marrow—lung cancer	4.82e-05	0.00109	CbGeAlD
Sunitinib—MAP3K7—lung—lung cancer	4.82e-05	0.00109	CbGeAlD
Sunitinib—TBK1—lung—lung cancer	4.77e-05	0.00107	CbGeAlD
Sunitinib—JAK2—bone marrow—lung cancer	4.76e-05	0.00107	CbGeAlD
Sunitinib—PHKG2—lymph node—lung cancer	4.75e-05	0.00107	CbGeAlD
Sunitinib—TYK2—lung—lung cancer	4.74e-05	0.00107	CbGeAlD
Sunitinib—KIT—epithelium—lung cancer	4.73e-05	0.00107	CbGeAlD
Sunitinib—STK24—lymph node—lung cancer	4.73e-05	0.00106	CbGeAlD
Sunitinib—MAP2K5—trachea—lung cancer	4.72e-05	0.00106	CbGeAlD
Sunitinib—KDR—trachea—lung cancer	4.72e-05	0.00106	CbGeAlD
Sunitinib—FYN—bone marrow—lung cancer	4.69e-05	0.00106	CbGeAlD
Sunitinib—IRAK1—lung—lung cancer	4.67e-05	0.00105	CbGeAlD
Sunitinib—DAPK2—lymph node—lung cancer	4.67e-05	0.00105	CbGeAlD
Sunitinib—KIT—bronchus—lung cancer	4.66e-05	0.00105	CbGeAlD
Sunitinib—PDGFRB—epithelium—lung cancer	4.62e-05	0.00104	CbGeAlD
Sunitinib—CSF1R—trachea—lung cancer	4.61e-05	0.00104	CbGeAlD
Sunitinib—STK16—lymph node—lung cancer	4.6e-05	0.00104	CbGeAlD
Sunitinib—RPS6KB1—lung—lung cancer	4.59e-05	0.00103	CbGeAlD
Sunitinib—MAP4K5—bone marrow—lung cancer	4.58e-05	0.00103	CbGeAlD
Sunitinib—MAP3K3—bone marrow—lung cancer	4.58e-05	0.00103	CbGeAlD
Sunitinib—HIPK2—lymph node—lung cancer	4.57e-05	0.00103	CbGeAlD
Sunitinib—HIPK3—lymph node—lung cancer	4.57e-05	0.00103	CbGeAlD
Sunitinib—ALK—lymph node—lung cancer	4.57e-05	0.00103	CbGeAlD
Sunitinib—FGR—lung—lung cancer	4.56e-05	0.00103	CbGeAlD
Sunitinib—PDGFRB—bronchus—lung cancer	4.55e-05	0.00103	CbGeAlD
Sunitinib—AXL—lung—lung cancer	4.54e-05	0.00102	CbGeAlD
Sunitinib—RIOK2—lymph node—lung cancer	4.53e-05	0.00102	CbGeAlD
Sunitinib—TNK1—lymph node—lung cancer	4.53e-05	0.00102	CbGeAlD
Sunitinib—MAP4K1—lymph node—lung cancer	4.48e-05	0.00101	CbGeAlD
Sunitinib—KDR—cardiac atrium—lung cancer	4.44e-05	0.000999	CbGeAlD
Sunitinib—MAP2K5—cardiac atrium—lung cancer	4.44e-05	0.000999	CbGeAlD
Sunitinib—DAPK3—lymph node—lung cancer	4.39e-05	0.00099	CbGeAlD
Sunitinib—SLK—lung—lung cancer	4.37e-05	0.000984	CbGeAlD
Sunitinib—CLK2—lymph node—lung cancer	4.35e-05	0.00098	CbGeAlD
Sunitinib—MAP4K2—lymph node—lung cancer	4.33e-05	0.000976	CbGeAlD
Sunitinib—FGFR2—lung—lung cancer	4.33e-05	0.000976	CbGeAlD
Sunitinib—CSF1R—cardiac atrium—lung cancer	4.33e-05	0.000975	CbGeAlD
Sunitinib—JAK2—lung—lung cancer	4.31e-05	0.00097	CbGeAlD
Sunitinib—STK3—lymph node—lung cancer	4.27e-05	0.000963	CbGeAlD
Sunitinib—FYN—lung—lung cancer	4.25e-05	0.000957	CbGeAlD
Sunitinib—YES1—bone marrow—lung cancer	4.23e-05	0.000953	CbGeAlD
Sunitinib—STK10—bone marrow—lung cancer	4.2e-05	0.000945	CbGeAlD
Sunitinib—KIT—trachea—lung cancer	4.19e-05	0.000943	CbGeAlD
Sunitinib—TAOK3—bone marrow—lung cancer	4.18e-05	0.000941	CbGeAlD
Sunitinib—MAP3K3—lung—lung cancer	4.15e-05	0.000935	CbGeAlD
Sunitinib—MAP4K5—lung—lung cancer	4.15e-05	0.000935	CbGeAlD
Sunitinib—CHEK2—Vindesine—Vinorelbine—lung cancer	4.14e-05	0.0287	CbGdCrCtD
Sunitinib—DYRK1A—lymph node—lung cancer	4.11e-05	0.000927	CbGeAlD
Sunitinib—PDGFRB—trachea—lung cancer	4.09e-05	0.000921	CbGeAlD
Sunitinib—MERTK—lymph node—lung cancer	4.02e-05	0.000905	CbGeAlD
Sunitinib—FLT1—lung—lung cancer	4.02e-05	0.000904	CbGeAlD
Sunitinib—EPHB6—lung—lung cancer	3.97e-05	0.000894	CbGeAlD
Sunitinib—MAP4K4—lymph node—lung cancer	3.94e-05	0.000888	CbGeAlD
Sunitinib—NUAK2—lymph node—lung cancer	3.92e-05	0.000882	CbGeAlD
Sunitinib—FLT3—lymph node—lung cancer	3.89e-05	0.000876	CbGeAlD
Sunitinib—MAP3K12—lymph node—lung cancer	3.89e-05	0.000876	CbGeAlD
Sunitinib—PDGFRB—cardiac atrium—lung cancer	3.84e-05	0.000865	CbGeAlD
Sunitinib—YES1—lung—lung cancer	3.84e-05	0.000864	CbGeAlD
Sunitinib—RPS6KA3—lymph node—lung cancer	3.84e-05	0.000864	CbGeAlD
Sunitinib—MAP2K1—lymph node—lung cancer	3.81e-05	0.000858	CbGeAlD
Sunitinib—STK10—lung—lung cancer	3.8e-05	0.000856	CbGeAlD
Sunitinib—TAOK3—lung—lung cancer	3.79e-05	0.000853	CbGeAlD
Sunitinib—PDGFRA—lung—lung cancer	3.76e-05	0.000847	CbGeAlD
Sunitinib—CSNK1A1—lymph node—lung cancer	3.76e-05	0.000847	CbGeAlD
Sunitinib—KDR—bone marrow—lung cancer	3.75e-05	0.000844	CbGeAlD
Sunitinib—CLK1—lymph node—lung cancer	3.74e-05	0.000841	CbGeAlD
Sunitinib—BMP2K—lymph node—lung cancer	3.67e-05	0.000826	CbGeAlD
Sunitinib—CAMK2G—lymph node—lung cancer	3.67e-05	0.000826	CbGeAlD
Sunitinib—CSF1R—bone marrow—lung cancer	3.66e-05	0.000823	CbGeAlD
Sunitinib—LRRK2—lymph node—lung cancer	3.63e-05	0.000819	CbGeAlD
Sunitinib—ABCC4—bronchus—lung cancer	3.63e-05	0.000817	CbGeAlD
Sunitinib—PRKAA1—lymph node—lung cancer	3.58e-05	0.000807	CbGeAlD
Sunitinib—PTK2B—lymph node—lung cancer	3.54e-05	0.000798	CbGeAlD
Sunitinib—FLT4—lymph node—lung cancer	3.53e-05	0.000795	CbGeAlD
Sunitinib—CHEK2—Podofilox—Teniposide—lung cancer	3.51e-05	0.0243	CbGdCrCtD
Sunitinib—CSNK1E—lymph node—lung cancer	3.48e-05	0.000785	CbGeAlD
Sunitinib—FGFR1—lymph node—lung cancer	3.48e-05	0.000785	CbGeAlD
Sunitinib—IRAK4—lymph node—lung cancer	3.43e-05	0.000773	CbGeAlD
Sunitinib—KDR—lung—lung cancer	3.39e-05	0.000764	CbGeAlD
Sunitinib—MAP2K5—lung—lung cancer	3.39e-05	0.000764	CbGeAlD
Sunitinib—CAMK2G—Azacitidine—Gemcitabine—lung cancer	3.36e-05	0.0233	CbGdCrCtD
Sunitinib—ULK3—lymph node—lung cancer	3.35e-05	0.000755	CbGeAlD
Sunitinib—MAP2K2—lymph node—lung cancer	3.35e-05	0.000755	CbGeAlD
Sunitinib—MAP3K2—lymph node—lung cancer	3.33e-05	0.00075	CbGeAlD
Sunitinib—KIT—bone marrow—lung cancer	3.32e-05	0.000748	CbGeAlD
Sunitinib—CSF1R—lung—lung cancer	3.31e-05	0.000746	CbGeAlD
Sunitinib—CHEK2—Vindesine—Vinblastine—lung cancer	3.31e-05	0.0229	CbGdCrCtD
Sunitinib—MAP3K7—lymph node—lung cancer	3.3e-05	0.000743	CbGeAlD
Sunitinib—TBK1—lymph node—lung cancer	3.26e-05	0.000734	CbGeAlD
Sunitinib—CHEK2—Paclitaxel—Docetaxel—lung cancer	3.25e-05	0.0225	CbGdCrCtD
Sunitinib—PDGFRB—bone marrow—lung cancer	3.24e-05	0.00073	CbGeAlD
Sunitinib—TYK2—lymph node—lung cancer	3.24e-05	0.00073	CbGeAlD
Sunitinib—IRAK1—lymph node—lung cancer	3.2e-05	0.00072	CbGeAlD
Sunitinib—RPS6KB1—lymph node—lung cancer	3.14e-05	0.000707	CbGeAlD
Sunitinib—FGR—lymph node—lung cancer	3.12e-05	0.000702	CbGeAlD
Sunitinib—RET—lymph node—lung cancer	3.12e-05	0.000702	CbGeAlD
Sunitinib—AXL—lymph node—lung cancer	3.11e-05	0.000699	CbGeAlD
Sunitinib—KIT—lung—lung cancer	3.01e-05	0.000677	CbGeAlD
Sunitinib—SLK—lymph node—lung cancer	2.99e-05	0.000673	CbGeAlD
Sunitinib—JAK2—lymph node—lung cancer	2.95e-05	0.000664	CbGeAlD
Sunitinib—PDGFRB—lung—lung cancer	2.94e-05	0.000662	CbGeAlD
Sunitinib—FYN—lymph node—lung cancer	2.91e-05	0.000655	CbGeAlD
Sunitinib—CYP3A5—respiratory system—lung cancer	2.89e-05	0.00065	CbGeAlD
Sunitinib—MAP3K3—lymph node—lung cancer	2.84e-05	0.00064	CbGeAlD
Sunitinib—MAP4K5—lymph node—lung cancer	2.84e-05	0.00064	CbGeAlD
Sunitinib—FLT1—lymph node—lung cancer	2.75e-05	0.000619	CbGeAlD
Sunitinib—EPHB6—lymph node—lung cancer	2.71e-05	0.000611	CbGeAlD
Sunitinib—YES1—lymph node—lung cancer	2.62e-05	0.000591	CbGeAlD
Sunitinib—STK10—lymph node—lung cancer	2.6e-05	0.000585	CbGeAlD
Sunitinib—TAOK3—lymph node—lung cancer	2.59e-05	0.000583	CbGeAlD
Sunitinib—ABCC4—bone marrow—lung cancer	2.58e-05	0.000582	CbGeAlD
Sunitinib—PDGFRA—lymph node—lung cancer	2.57e-05	0.00058	CbGeAlD
Sunitinib—KCNH2—cardiac atrium—lung cancer	2.43e-05	0.000547	CbGeAlD
Sunitinib—PLK4—Teniposide—Etoposide—lung cancer	2.37e-05	0.0164	CbGdCrCtD
Sunitinib—ABCC4—lung—lung cancer	2.34e-05	0.000527	CbGeAlD
Sunitinib—MAP2K5—lymph node—lung cancer	2.32e-05	0.000523	CbGeAlD
Sunitinib—KDR—lymph node—lung cancer	2.32e-05	0.000523	CbGeAlD
Sunitinib—CSF1R—lymph node—lung cancer	2.27e-05	0.00051	CbGeAlD
Sunitinib—CHEK2—Vincristine—Vinorelbine—lung cancer	2.23e-05	0.0155	CbGdCrCtD
Sunitinib—CHEK2—Vinorelbine—Vinblastine—lung cancer	2.09e-05	0.0145	CbGdCrCtD
Sunitinib—CHEK2—Teniposide—Etoposide—lung cancer	2.09e-05	0.0145	CbGdCrCtD
Sunitinib—CHEK2—Podofilox—Etoposide—lung cancer	2.09e-05	0.0145	CbGdCrCtD
Sunitinib—KIT—lymph node—lung cancer	2.06e-05	0.000463	CbGeAlD
Sunitinib—KCNH2—bone marrow—lung cancer	2.05e-05	0.000461	CbGeAlD
Sunitinib—PDGFRB—lymph node—lung cancer	2.01e-05	0.000453	CbGeAlD
Sunitinib—ABCG2—bone marrow—lung cancer	1.82e-05	0.00041	CbGeAlD
Sunitinib—CHEK2—Vinblastine—Vinorelbine—lung cancer	1.8e-05	0.0125	CbGdCrCtD
Sunitinib—CHEK2—Vincristine—Vinblastine—lung cancer	1.79e-05	0.0124	CbGdCrCtD
Sunitinib—RPS6KA1—Azacitidine—Gemcitabine—lung cancer	1.72e-05	0.0119	CbGdCrCtD
Sunitinib—DYRK1A—Idarubicin—Doxorubicin—lung cancer	1.67e-05	0.0116	CbGdCrCtD
Sunitinib—DYRK1A—Epirubicin—Doxorubicin—lung cancer	1.67e-05	0.0116	CbGdCrCtD
Sunitinib—DYRK1A—Daunorubicin—Doxorubicin—lung cancer	1.67e-05	0.0116	CbGdCrCtD
Sunitinib—ABCG2—lung—lung cancer	1.65e-05	0.000372	CbGeAlD
Sunitinib—ABCC4—lymph node—lung cancer	1.6e-05	0.00036	CbGeAlD
Sunitinib—ABCC2—lymph node—lung cancer	1.55e-05	0.000349	CbGeAlD
Sunitinib—ABCB1—respiratory system—lung cancer	1.53e-05	0.000345	CbGeAlD
Sunitinib—CYP3A5—lung—lung cancer	1.53e-05	0.000345	CbGeAlD
Sunitinib—PRPF4—Idarubicin—Doxorubicin—lung cancer	1.44e-05	0.01	CbGdCrCtD
Sunitinib—PRPF4—Daunorubicin—Doxorubicin—lung cancer	1.44e-05	0.01	CbGdCrCtD
Sunitinib—Abdominal distension—Doxorubicin—lung cancer	1.33e-05	0.00021	CcSEcCtD
Sunitinib—Stomatitis—Methotrexate—lung cancer	1.32e-05	0.000209	CcSEcCtD
Sunitinib—Headache—Vinorelbine—lung cancer	1.32e-05	0.000209	CcSEcCtD
Sunitinib—Dysphagia—Doxorubicin—lung cancer	1.32e-05	0.000209	CcSEcCtD
Sunitinib—Leukopenia—Docetaxel—lung cancer	1.32e-05	0.000208	CcSEcCtD
Sunitinib—Paraesthesia—Etoposide—lung cancer	1.3e-05	0.000205	CcSEcCtD
Sunitinib—Pancreatitis—Doxorubicin—lung cancer	1.29e-05	0.000205	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Paclitaxel—lung cancer	1.29e-05	0.000204	CcSEcCtD
Sunitinib—Dyspnoea—Etoposide—lung cancer	1.29e-05	0.000204	CcSEcCtD
Sunitinib—Cough—Docetaxel—lung cancer	1.28e-05	0.000203	CcSEcCtD
Sunitinib—Hepatobiliary disease—Methotrexate—lung cancer	1.28e-05	0.000203	CcSEcCtD
Sunitinib—ABCB1—epithelium—lung cancer	1.28e-05	0.000289	CbGeAlD
Sunitinib—Insomnia—Paclitaxel—lung cancer	1.28e-05	0.000203	CcSEcCtD
Sunitinib—Epistaxis—Methotrexate—lung cancer	1.28e-05	0.000203	CcSEcCtD
Sunitinib—Hypersensitivity—Irinotecan—lung cancer	1.28e-05	0.000203	CcSEcCtD
Sunitinib—Convulsion—Docetaxel—lung cancer	1.27e-05	0.000202	CcSEcCtD
Sunitinib—Paraesthesia—Paclitaxel—lung cancer	1.27e-05	0.000201	CcSEcCtD
Sunitinib—KCNH2—lymph node—lung cancer	1.27e-05	0.000286	CbGeAlD
Sunitinib—Hypertension—Docetaxel—lung cancer	1.27e-05	0.000201	CcSEcCtD
Sunitinib—Bronchitis—Doxorubicin—lung cancer	1.27e-05	0.000201	CcSEcCtD
Sunitinib—Dyspnoea—Paclitaxel—lung cancer	1.26e-05	0.0002	CcSEcCtD
Sunitinib—Decreased appetite—Etoposide—lung cancer	1.25e-05	0.000199	CcSEcCtD
Sunitinib—Chest pain—Docetaxel—lung cancer	1.25e-05	0.000198	CcSEcCtD
Sunitinib—Myalgia—Docetaxel—lung cancer	1.25e-05	0.000198	CcSEcCtD
Sunitinib—Arthralgia—Docetaxel—lung cancer	1.25e-05	0.000198	CcSEcCtD
Sunitinib—Pancytopenia—Doxorubicin—lung cancer	1.25e-05	0.000198	CcSEcCtD
Sunitinib—Nausea—Vinorelbine—lung cancer	1.25e-05	0.000198	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Etoposide—lung cancer	1.25e-05	0.000197	CcSEcCtD
Sunitinib—Dyspepsia—Paclitaxel—lung cancer	1.25e-05	0.000197	CcSEcCtD
Sunitinib—Body temperature increased—Cisplatin—lung cancer	1.25e-05	0.000197	CcSEcCtD
Sunitinib—Asthenia—Irinotecan—lung cancer	1.25e-05	0.000197	CcSEcCtD
Sunitinib—Fatigue—Etoposide—lung cancer	1.24e-05	0.000197	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	1.24e-05	0.000197	CcSEcCtD
Sunitinib—Pain—Etoposide—lung cancer	1.23e-05	0.000196	CcSEcCtD
Sunitinib—Constipation—Etoposide—lung cancer	1.23e-05	0.000196	CcSEcCtD
Sunitinib—Neutropenia—Doxorubicin—lung cancer	1.23e-05	0.000195	CcSEcCtD
Sunitinib—Decreased appetite—Paclitaxel—lung cancer	1.23e-05	0.000195	CcSEcCtD
Sunitinib—Dry mouth—Docetaxel—lung cancer	1.22e-05	0.000194	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Doxorubicin—lung cancer	1.22e-05	0.000194	CcSEcCtD
Sunitinib—Haemoglobin—Methotrexate—lung cancer	1.22e-05	0.000194	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Paclitaxel—lung cancer	1.22e-05	0.000194	CcSEcCtD
Sunitinib—Fatigue—Paclitaxel—lung cancer	1.22e-05	0.000193	CcSEcCtD
Sunitinib—Haemorrhage—Methotrexate—lung cancer	1.22e-05	0.000193	CcSEcCtD
Sunitinib—Hepatitis—Methotrexate—lung cancer	1.22e-05	0.000193	CcSEcCtD
Sunitinib—Asthenia—Gemcitabine—lung cancer	1.21e-05	0.000192	CcSEcCtD
Sunitinib—Pain—Paclitaxel—lung cancer	1.21e-05	0.000192	CcSEcCtD
Sunitinib—Constipation—Paclitaxel—lung cancer	1.21e-05	0.000192	CcSEcCtD
Sunitinib—Urinary tract disorder—Methotrexate—lung cancer	1.2e-05	0.00019	CcSEcCtD
Sunitinib—Oedema—Docetaxel—lung cancer	1.2e-05	0.00019	CcSEcCtD
Sunitinib—Pruritus—Gemcitabine—lung cancer	1.2e-05	0.00019	CcSEcCtD
Sunitinib—Urethral disorder—Methotrexate—lung cancer	1.19e-05	0.000189	CcSEcCtD
Sunitinib—Infection—Docetaxel—lung cancer	1.19e-05	0.000189	CcSEcCtD
Sunitinib—Weight decreased—Doxorubicin—lung cancer	1.19e-05	0.000189	CcSEcCtD
Sunitinib—Hyperglycaemia—Doxorubicin—lung cancer	1.19e-05	0.000188	CcSEcCtD
Sunitinib—Diarrhoea—Irinotecan—lung cancer	1.19e-05	0.000188	CcSEcCtD
Sunitinib—Pneumonia—Doxorubicin—lung cancer	1.18e-05	0.000187	CcSEcCtD
Sunitinib—Gastrointestinal pain—Etoposide—lung cancer	1.18e-05	0.000187	CcSEcCtD
Sunitinib—Shock—Docetaxel—lung cancer	1.18e-05	0.000187	CcSEcCtD
Sunitinib—Nervous system disorder—Docetaxel—lung cancer	1.18e-05	0.000186	CcSEcCtD
Sunitinib—Thrombocytopenia—Docetaxel—lung cancer	1.17e-05	0.000186	CcSEcCtD
Sunitinib—Infestation NOS—Doxorubicin—lung cancer	1.17e-05	0.000186	CcSEcCtD
Sunitinib—Infestation—Doxorubicin—lung cancer	1.17e-05	0.000186	CcSEcCtD
Sunitinib—Skin disorder—Docetaxel—lung cancer	1.17e-05	0.000185	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Doxorubicin—lung cancer	1.16e-05	0.000184	CcSEcCtD
Sunitinib—Hypersensitivity—Cisplatin—lung cancer	1.16e-05	0.000184	CcSEcCtD
Sunitinib—Gastrointestinal pain—Paclitaxel—lung cancer	1.16e-05	0.000183	CcSEcCtD
Sunitinib—Diarrhoea—Gemcitabine—lung cancer	1.16e-05	0.000183	CcSEcCtD
Sunitinib—Renal failure—Doxorubicin—lung cancer	1.15e-05	0.000183	CcSEcCtD
Sunitinib—Erythema multiforme—Methotrexate—lung cancer	1.15e-05	0.000182	CcSEcCtD
Sunitinib—Neuropathy peripheral—Doxorubicin—lung cancer	1.15e-05	0.000182	CcSEcCtD
Sunitinib—Dizziness—Irinotecan—lung cancer	1.15e-05	0.000182	CcSEcCtD
Sunitinib—Stomatitis—Doxorubicin—lung cancer	1.14e-05	0.000181	CcSEcCtD
Sunitinib—Anorexia—Docetaxel—lung cancer	1.14e-05	0.000181	CcSEcCtD
Sunitinib—PLK4—Epirubicin—Doxorubicin—lung cancer	1.14e-05	0.00792	CbGdCrCtD
Sunitinib—PLK4—Idarubicin—Doxorubicin—lung cancer	1.14e-05	0.00792	CbGdCrCtD
Sunitinib—Abdominal pain—Etoposide—lung cancer	1.14e-05	0.000181	CcSEcCtD
Sunitinib—Body temperature increased—Etoposide—lung cancer	1.14e-05	0.000181	CcSEcCtD
Sunitinib—Urinary tract infection—Doxorubicin—lung cancer	1.14e-05	0.000181	CcSEcCtD
Sunitinib—Eye disorder—Methotrexate—lung cancer	1.14e-05	0.00018	CcSEcCtD
Sunitinib—ABCB1—trachea—lung cancer	1.13e-05	0.000255	CbGeAlD
Sunitinib—Asthenia—Cisplatin—lung cancer	1.13e-05	0.000179	CcSEcCtD
Sunitinib—Cardiac disorder—Methotrexate—lung cancer	1.13e-05	0.000179	CcSEcCtD
Sunitinib—ABCG2—lymph node—lung cancer	1.13e-05	0.000254	CbGeAlD
Sunitinib—Body temperature increased—Paclitaxel—lung cancer	1.12e-05	0.000177	CcSEcCtD
Sunitinib—Abdominal pain—Paclitaxel—lung cancer	1.12e-05	0.000177	CcSEcCtD
Sunitinib—Hepatobiliary disease—Doxorubicin—lung cancer	1.11e-05	0.000176	CcSEcCtD
Sunitinib—Epistaxis—Doxorubicin—lung cancer	1.11e-05	0.000175	CcSEcCtD
Sunitinib—Angiopathy—Methotrexate—lung cancer	1.1e-05	0.000175	CcSEcCtD
Sunitinib—Vomiting—Irinotecan—lung cancer	1.1e-05	0.000175	CcSEcCtD
Sunitinib—Immune system disorder—Methotrexate—lung cancer	1.1e-05	0.000174	CcSEcCtD
Sunitinib—Mediastinal disorder—Methotrexate—lung cancer	1.1e-05	0.000174	CcSEcCtD
Sunitinib—Rash—Irinotecan—lung cancer	1.09e-05	0.000173	CcSEcCtD
Sunitinib—Dermatitis—Irinotecan—lung cancer	1.09e-05	0.000173	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Docetaxel—lung cancer	1.09e-05	0.000173	CcSEcCtD
Sunitinib—Chills—Methotrexate—lung cancer	1.09e-05	0.000173	CcSEcCtD
Sunitinib—Headache—Irinotecan—lung cancer	1.09e-05	0.000172	CcSEcCtD
Sunitinib—Insomnia—Docetaxel—lung cancer	1.09e-05	0.000172	CcSEcCtD
Sunitinib—Diarrhoea—Cisplatin—lung cancer	1.08e-05	0.000171	CcSEcCtD
Sunitinib—Paraesthesia—Docetaxel—lung cancer	1.08e-05	0.000171	CcSEcCtD
Sunitinib—Alopecia—Methotrexate—lung cancer	1.08e-05	0.00017	CcSEcCtD
Sunitinib—Vomiting—Gemcitabine—lung cancer	1.07e-05	0.00017	CcSEcCtD
Sunitinib—Bradycardia—Doxorubicin—lung cancer	1.07e-05	0.00017	CcSEcCtD
Sunitinib—Dyspnoea—Docetaxel—lung cancer	1.07e-05	0.000169	CcSEcCtD
Sunitinib—Mental disorder—Methotrexate—lung cancer	1.07e-05	0.000169	CcSEcCtD
Sunitinib—Rash—Gemcitabine—lung cancer	1.07e-05	0.000169	CcSEcCtD
Sunitinib—Dermatitis—Gemcitabine—lung cancer	1.06e-05	0.000169	CcSEcCtD
Sunitinib—Hypersensitivity—Etoposide—lung cancer	1.06e-05	0.000169	CcSEcCtD
Sunitinib—Malnutrition—Methotrexate—lung cancer	1.06e-05	0.000168	CcSEcCtD
Sunitinib—Erythema—Methotrexate—lung cancer	1.06e-05	0.000168	CcSEcCtD
Sunitinib—Haemoglobin—Doxorubicin—lung cancer	1.06e-05	0.000168	CcSEcCtD
Sunitinib—Headache—Gemcitabine—lung cancer	1.06e-05	0.000168	CcSEcCtD
Sunitinib—Dyspepsia—Docetaxel—lung cancer	1.06e-05	0.000167	CcSEcCtD
Sunitinib—Haemorrhage—Doxorubicin—lung cancer	1.05e-05	0.000167	CcSEcCtD
Sunitinib—Hepatitis—Doxorubicin—lung cancer	1.05e-05	0.000167	CcSEcCtD
Sunitinib—Hypoaesthesia—Doxorubicin—lung cancer	1.05e-05	0.000166	CcSEcCtD
Sunitinib—Decreased appetite—Docetaxel—lung cancer	1.04e-05	0.000165	CcSEcCtD
Sunitinib—Hypersensitivity—Paclitaxel—lung cancer	1.04e-05	0.000165	CcSEcCtD
Sunitinib—Urinary tract disorder—Doxorubicin—lung cancer	1.04e-05	0.000165	CcSEcCtD
Sunitinib—Oedema peripheral—Doxorubicin—lung cancer	1.04e-05	0.000164	CcSEcCtD
Sunitinib—Dysgeusia—Methotrexate—lung cancer	1.04e-05	0.000164	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Docetaxel—lung cancer	1.04e-05	0.000164	CcSEcCtD
Sunitinib—Asthenia—Etoposide—lung cancer	1.04e-05	0.000164	CcSEcCtD
Sunitinib—Connective tissue disorder—Doxorubicin—lung cancer	1.04e-05	0.000164	CcSEcCtD
Sunitinib—Fatigue—Docetaxel—lung cancer	1.03e-05	0.000164	CcSEcCtD
Sunitinib—Urethral disorder—Doxorubicin—lung cancer	1.03e-05	0.000164	CcSEcCtD
Sunitinib—Nausea—Irinotecan—lung cancer	1.03e-05	0.000163	CcSEcCtD
Sunitinib—Pain—Docetaxel—lung cancer	1.03e-05	0.000163	CcSEcCtD
Sunitinib—Constipation—Docetaxel—lung cancer	1.03e-05	0.000163	CcSEcCtD
Sunitinib—Back pain—Methotrexate—lung cancer	1.02e-05	0.000162	CcSEcCtD
Sunitinib—Pruritus—Etoposide—lung cancer	1.02e-05	0.000162	CcSEcCtD
Sunitinib—Asthenia—Paclitaxel—lung cancer	1.02e-05	0.000161	CcSEcCtD
Sunitinib—CHEK2—Epirubicin—Doxorubicin—lung cancer	1.01e-05	0.00698	CbGdCrCtD
Sunitinib—Nausea—Gemcitabine—lung cancer	1e-05	0.000159	CcSEcCtD
Sunitinib—Vomiting—Cisplatin—lung cancer	1e-05	0.000159	CcSEcCtD
Sunitinib—Pruritus—Paclitaxel—lung cancer	1e-05	0.000159	CcSEcCtD
Sunitinib—Erythema multiforme—Doxorubicin—lung cancer	9.96e-06	0.000158	CcSEcCtD
Sunitinib—Rash—Cisplatin—lung cancer	9.94e-06	0.000157	CcSEcCtD
Sunitinib—Dermatitis—Cisplatin—lung cancer	9.93e-06	0.000157	CcSEcCtD
Sunitinib—Diarrhoea—Etoposide—lung cancer	9.88e-06	0.000156	CcSEcCtD
Sunitinib—Eye disorder—Doxorubicin—lung cancer	9.85e-06	0.000156	CcSEcCtD
Sunitinib—Gastrointestinal pain—Docetaxel—lung cancer	9.81e-06	0.000155	CcSEcCtD
Sunitinib—Anaemia—Methotrexate—lung cancer	9.79e-06	0.000155	CcSEcCtD
Sunitinib—Flushing—Doxorubicin—lung cancer	9.78e-06	0.000155	CcSEcCtD
Sunitinib—Cardiac disorder—Doxorubicin—lung cancer	9.78e-06	0.000155	CcSEcCtD
Sunitinib—Diarrhoea—Paclitaxel—lung cancer	9.68e-06	0.000153	CcSEcCtD
Sunitinib—Angiopathy—Doxorubicin—lung cancer	9.56e-06	0.000151	CcSEcCtD
Sunitinib—Dizziness—Etoposide—lung cancer	9.55e-06	0.000151	CcSEcCtD
Sunitinib—Immune system disorder—Doxorubicin—lung cancer	9.52e-06	0.000151	CcSEcCtD
Sunitinib—Mediastinal disorder—Doxorubicin—lung cancer	9.5e-06	0.00015	CcSEcCtD
Sunitinib—Abdominal pain—Docetaxel—lung cancer	9.48e-06	0.00015	CcSEcCtD
Sunitinib—Body temperature increased—Docetaxel—lung cancer	9.48e-06	0.00015	CcSEcCtD
Sunitinib—Leukopenia—Methotrexate—lung cancer	9.48e-06	0.00015	CcSEcCtD
Sunitinib—Chills—Doxorubicin—lung cancer	9.46e-06	0.00015	CcSEcCtD
Sunitinib—Arrhythmia—Doxorubicin—lung cancer	9.42e-06	0.000149	CcSEcCtD
Sunitinib—Dizziness—Paclitaxel—lung cancer	9.36e-06	0.000148	CcSEcCtD
Sunitinib—Nausea—Cisplatin—lung cancer	9.36e-06	0.000148	CcSEcCtD
Sunitinib—Alopecia—Doxorubicin—lung cancer	9.31e-06	0.000148	CcSEcCtD
Sunitinib—Cough—Methotrexate—lung cancer	9.25e-06	0.000146	CcSEcCtD
Sunitinib—Mental disorder—Doxorubicin—lung cancer	9.23e-06	0.000146	CcSEcCtD
Sunitinib—Convulsion—Methotrexate—lung cancer	9.18e-06	0.000145	CcSEcCtD
Sunitinib—Vomiting—Etoposide—lung cancer	9.18e-06	0.000145	CcSEcCtD
Sunitinib—Erythema—Doxorubicin—lung cancer	9.17e-06	0.000145	CcSEcCtD
Sunitinib—Malnutrition—Doxorubicin—lung cancer	9.17e-06	0.000145	CcSEcCtD
Sunitinib—Rash—Etoposide—lung cancer	9.1e-06	0.000144	CcSEcCtD
Sunitinib—Dermatitis—Etoposide—lung cancer	9.09e-06	0.000144	CcSEcCtD
Sunitinib—Headache—Etoposide—lung cancer	9.04e-06	0.000143	CcSEcCtD
Sunitinib—Flatulence—Doxorubicin—lung cancer	9.04e-06	0.000143	CcSEcCtD
Sunitinib—Arthralgia—Methotrexate—lung cancer	9.02e-06	0.000143	CcSEcCtD
Sunitinib—Chest pain—Methotrexate—lung cancer	9.02e-06	0.000143	CcSEcCtD
Sunitinib—Myalgia—Methotrexate—lung cancer	9.02e-06	0.000143	CcSEcCtD
Sunitinib—Vomiting—Paclitaxel—lung cancer	9e-06	0.000143	CcSEcCtD
Sunitinib—ABCB1—bone marrow—lung cancer	8.99e-06	0.000202	CbGeAlD
Sunitinib—Dysgeusia—Doxorubicin—lung cancer	8.98e-06	0.000142	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	8.96e-06	0.000142	CcSEcCtD
Sunitinib—Rash—Paclitaxel—lung cancer	8.92e-06	0.000141	CcSEcCtD
Sunitinib—Dermatitis—Paclitaxel—lung cancer	8.92e-06	0.000141	CcSEcCtD
Sunitinib—Back pain—Doxorubicin—lung cancer	8.87e-06	0.000141	CcSEcCtD
Sunitinib—Headache—Paclitaxel—lung cancer	8.87e-06	0.00014	CcSEcCtD
Sunitinib—Hypersensitivity—Docetaxel—lung cancer	8.84e-06	0.00014	CcSEcCtD
Sunitinib—Muscle spasms—Doxorubicin—lung cancer	8.82e-06	0.00014	CcSEcCtD
Sunitinib—Asthenia—Docetaxel—lung cancer	8.61e-06	0.000136	CcSEcCtD
Sunitinib—Infection—Methotrexate—lung cancer	8.59e-06	0.000136	CcSEcCtD
Sunitinib—Nausea—Etoposide—lung cancer	8.58e-06	0.000136	CcSEcCtD
Sunitinib—Pruritus—Docetaxel—lung cancer	8.49e-06	0.000134	CcSEcCtD
Sunitinib—Nervous system disorder—Methotrexate—lung cancer	8.48e-06	0.000134	CcSEcCtD
Sunitinib—Anaemia—Doxorubicin—lung cancer	8.48e-06	0.000134	CcSEcCtD
Sunitinib—Thrombocytopenia—Methotrexate—lung cancer	8.47e-06	0.000134	CcSEcCtD
Sunitinib—Nausea—Paclitaxel—lung cancer	8.41e-06	0.000133	CcSEcCtD
Sunitinib—Skin disorder—Methotrexate—lung cancer	8.4e-06	0.000133	CcSEcCtD
Sunitinib—Anorexia—Methotrexate—lung cancer	8.24e-06	0.000131	CcSEcCtD
Sunitinib—Leukopenia—Doxorubicin—lung cancer	8.21e-06	0.00013	CcSEcCtD
Sunitinib—Diarrhoea—Docetaxel—lung cancer	8.21e-06	0.00013	CcSEcCtD
Sunitinib—ABCB1—lung—lung cancer	8.14e-06	0.000183	CbGeAlD
Sunitinib—Cough—Doxorubicin—lung cancer	8.01e-06	0.000127	CcSEcCtD
Sunitinib—Convulsion—Doxorubicin—lung cancer	7.95e-06	0.000126	CcSEcCtD
Sunitinib—Dizziness—Docetaxel—lung cancer	7.93e-06	0.000126	CcSEcCtD
Sunitinib—Hypertension—Doxorubicin—lung cancer	7.92e-06	0.000125	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methotrexate—lung cancer	7.88e-06	0.000125	CcSEcCtD
Sunitinib—Insomnia—Methotrexate—lung cancer	7.82e-06	0.000124	CcSEcCtD
Sunitinib—Myalgia—Doxorubicin—lung cancer	7.81e-06	0.000124	CcSEcCtD
Sunitinib—Arthralgia—Doxorubicin—lung cancer	7.81e-06	0.000124	CcSEcCtD
Sunitinib—Chest pain—Doxorubicin—lung cancer	7.81e-06	0.000124	CcSEcCtD
Sunitinib—Paraesthesia—Methotrexate—lung cancer	7.76e-06	0.000123	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	7.76e-06	0.000123	CcSEcCtD
Sunitinib—Dyspnoea—Methotrexate—lung cancer	7.71e-06	0.000122	CcSEcCtD
Sunitinib—Dry mouth—Doxorubicin—lung cancer	7.64e-06	0.000121	CcSEcCtD
Sunitinib—Vomiting—Docetaxel—lung cancer	7.63e-06	0.000121	CcSEcCtD
Sunitinib—Dyspepsia—Methotrexate—lung cancer	7.61e-06	0.000121	CcSEcCtD
Sunitinib—Rash—Docetaxel—lung cancer	7.56e-06	0.00012	CcSEcCtD
Sunitinib—Dermatitis—Docetaxel—lung cancer	7.56e-06	0.00012	CcSEcCtD
Sunitinib—Decreased appetite—Methotrexate—lung cancer	7.52e-06	0.000119	CcSEcCtD
Sunitinib—Headache—Docetaxel—lung cancer	7.52e-06	0.000119	CcSEcCtD
Sunitinib—Oedema—Doxorubicin—lung cancer	7.49e-06	0.000119	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Methotrexate—lung cancer	7.47e-06	0.000118	CcSEcCtD
Sunitinib—Fatigue—Methotrexate—lung cancer	7.46e-06	0.000118	CcSEcCtD
Sunitinib—Infection—Doxorubicin—lung cancer	7.44e-06	0.000118	CcSEcCtD
Sunitinib—Pain—Methotrexate—lung cancer	7.39e-06	0.000117	CcSEcCtD
Sunitinib—Shock—Doxorubicin—lung cancer	7.37e-06	0.000117	CcSEcCtD
Sunitinib—Nervous system disorder—Doxorubicin—lung cancer	7.34e-06	0.000116	CcSEcCtD
Sunitinib—Thrombocytopenia—Doxorubicin—lung cancer	7.33e-06	0.000116	CcSEcCtD
Sunitinib—Skin disorder—Doxorubicin—lung cancer	7.27e-06	0.000115	CcSEcCtD
Sunitinib—Anorexia—Doxorubicin—lung cancer	7.14e-06	0.000113	CcSEcCtD
Sunitinib—Nausea—Docetaxel—lung cancer	7.13e-06	0.000113	CcSEcCtD
Sunitinib—Gastrointestinal pain—Methotrexate—lung cancer	7.07e-06	0.000112	CcSEcCtD
Sunitinib—Abdominal pain—Methotrexate—lung cancer	6.84e-06	0.000108	CcSEcCtD
Sunitinib—Body temperature increased—Methotrexate—lung cancer	6.84e-06	0.000108	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Doxorubicin—lung cancer	6.82e-06	0.000108	CcSEcCtD
Sunitinib—Insomnia—Doxorubicin—lung cancer	6.77e-06	0.000107	CcSEcCtD
Sunitinib—Paraesthesia—Doxorubicin—lung cancer	6.72e-06	0.000107	CcSEcCtD
Sunitinib—Dyspnoea—Doxorubicin—lung cancer	6.68e-06	0.000106	CcSEcCtD
Sunitinib—Dyspepsia—Doxorubicin—lung cancer	6.59e-06	0.000104	CcSEcCtD
Sunitinib—Decreased appetite—Doxorubicin—lung cancer	6.51e-06	0.000103	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Doxorubicin—lung cancer	6.46e-06	0.000102	CcSEcCtD
Sunitinib—Fatigue—Doxorubicin—lung cancer	6.46e-06	0.000102	CcSEcCtD
Sunitinib—Constipation—Doxorubicin—lung cancer	6.4e-06	0.000101	CcSEcCtD
Sunitinib—Pain—Doxorubicin—lung cancer	6.4e-06	0.000101	CcSEcCtD
Sunitinib—Hypersensitivity—Methotrexate—lung cancer	6.37e-06	0.000101	CcSEcCtD
Sunitinib—Asthenia—Methotrexate—lung cancer	6.2e-06	9.83e-05	CcSEcCtD
Sunitinib—Gastrointestinal pain—Doxorubicin—lung cancer	6.12e-06	9.7e-05	CcSEcCtD
Sunitinib—Pruritus—Methotrexate—lung cancer	6.12e-06	9.69e-05	CcSEcCtD
Sunitinib—Abdominal pain—Doxorubicin—lung cancer	5.92e-06	9.38e-05	CcSEcCtD
Sunitinib—Body temperature increased—Doxorubicin—lung cancer	5.92e-06	9.38e-05	CcSEcCtD
Sunitinib—Diarrhoea—Methotrexate—lung cancer	5.92e-06	9.37e-05	CcSEcCtD
Sunitinib—Dizziness—Methotrexate—lung cancer	5.72e-06	9.06e-05	CcSEcCtD
Sunitinib—ABCB1—lymph node—lung cancer	5.57e-06	0.000125	CbGeAlD
Sunitinib—Hypersensitivity—Doxorubicin—lung cancer	5.52e-06	8.74e-05	CcSEcCtD
Sunitinib—Vomiting—Methotrexate—lung cancer	5.5e-06	8.71e-05	CcSEcCtD
Sunitinib—Rash—Methotrexate—lung cancer	5.45e-06	8.64e-05	CcSEcCtD
Sunitinib—Dermatitis—Methotrexate—lung cancer	5.45e-06	8.63e-05	CcSEcCtD
Sunitinib—Headache—Methotrexate—lung cancer	5.42e-06	8.58e-05	CcSEcCtD
Sunitinib—Asthenia—Doxorubicin—lung cancer	5.37e-06	8.51e-05	CcSEcCtD
Sunitinib—Pruritus—Doxorubicin—lung cancer	5.3e-06	8.39e-05	CcSEcCtD
Sunitinib—Nausea—Methotrexate—lung cancer	5.14e-06	8.14e-05	CcSEcCtD
Sunitinib—Diarrhoea—Doxorubicin—lung cancer	5.12e-06	8.12e-05	CcSEcCtD
Sunitinib—Dizziness—Doxorubicin—lung cancer	4.95e-06	7.84e-05	CcSEcCtD
Sunitinib—Vomiting—Doxorubicin—lung cancer	4.76e-06	7.54e-05	CcSEcCtD
Sunitinib—Rash—Doxorubicin—lung cancer	4.72e-06	7.48e-05	CcSEcCtD
Sunitinib—Dermatitis—Doxorubicin—lung cancer	4.72e-06	7.47e-05	CcSEcCtD
Sunitinib—Headache—Doxorubicin—lung cancer	4.69e-06	7.43e-05	CcSEcCtD
Sunitinib—Nausea—Doxorubicin—lung cancer	4.45e-06	7.05e-05	CcSEcCtD
Sunitinib—MAP2K2—Immune System—IL6—lung cancer	1.16e-07	1.48e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—lung cancer	1.16e-07	1.48e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTT1—lung cancer	1.16e-07	1.48e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—HRAS—lung cancer	1.15e-07	1.48e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—lung cancer	1.15e-07	1.48e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—lung cancer	1.15e-07	1.47e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—lung cancer	1.15e-07	1.47e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCLC—lung cancer	1.14e-07	1.47e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2A6—lung cancer	1.14e-07	1.47e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EP300—lung cancer	1.14e-07	1.46e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CASP3—lung cancer	1.14e-07	1.46e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MYC—lung cancer	1.14e-07	1.46e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MYC—lung cancer	1.14e-07	1.46e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2—lung cancer	1.14e-07	1.46e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—HRAS—lung cancer	1.14e-07	1.46e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PIK3CA—lung cancer	1.13e-07	1.46e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP1A1—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HRAS—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CDKN1A—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PIK3CA—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—lung cancer	1.13e-07	1.45e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PTEN—lung cancer	1.13e-07	1.44e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—lung cancer	1.13e-07	1.44e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ERCC2—lung cancer	1.12e-07	1.44e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CDKN1A—lung cancer	1.12e-07	1.44e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PTEN—lung cancer	1.12e-07	1.44e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—lung cancer	1.12e-07	1.44e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—KRAS—lung cancer	1.12e-07	1.43e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—HRAS—lung cancer	1.12e-07	1.43e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EP300—lung cancer	1.11e-07	1.43e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—lung cancer	1.11e-07	1.43e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—lung cancer	1.11e-07	1.43e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MAPK3—lung cancer	1.11e-07	1.43e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SRC—lung cancer	1.11e-07	1.42e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCND1—lung cancer	1.11e-07	1.42e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MAPK3—lung cancer	1.11e-07	1.42e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—JUN—lung cancer	1.11e-07	1.42e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—lung cancer	1.1e-07	1.42e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—lung cancer	1.09e-07	1.4e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CREBBP—lung cancer	1.09e-07	1.4e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—HRAS—lung cancer	1.09e-07	1.4e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—lung cancer	1.09e-07	1.4e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTEN—lung cancer	1.09e-07	1.39e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—KRAS—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SRC—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ENO1—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PIK3CA—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HRAS—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MYC—lung cancer	1.08e-07	1.39e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PIK3CA—lung cancer	1.08e-07	1.38e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MYC—lung cancer	1.08e-07	1.38e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—lung cancer	1.08e-07	1.38e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—lung cancer	1.08e-07	1.38e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTEN—lung cancer	1.08e-07	1.38e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EP300—lung cancer	1.07e-07	1.38e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CDKN1A—lung cancer	1.07e-07	1.38e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—KRAS—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PTEN—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EP300—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NRAS—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—lung cancer	1.07e-07	1.37e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—lung cancer	1.06e-07	1.36e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—lung cancer	1.06e-07	1.35e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—lung cancer	1.05e-07	1.35e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—KRAS—lung cancer	1.05e-07	1.35e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—KRAS—lung cancer	1.05e-07	1.35e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—HRAS—lung cancer	1.05e-07	1.35e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TP53—lung cancer	1.05e-07	1.34e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—lung cancer	1.05e-07	1.34e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—lung cancer	1.05e-07	1.34e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—lung cancer	1.05e-07	1.34e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SRC—lung cancer	1.04e-07	1.34e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—lung cancer	1.04e-07	1.34e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—HRAS—lung cancer	1.04e-07	1.34e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NRAS—lung cancer	1.04e-07	1.34e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—lung cancer	1.04e-07	1.34e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—lung cancer	1.04e-07	1.34e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SRC—lung cancer	1.04e-07	1.33e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—EP300—lung cancer	1.04e-07	1.33e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—lung cancer	1.03e-07	1.33e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CD—lung cancer	1.03e-07	1.33e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—EP300—lung cancer	1.03e-07	1.32e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PIK3CA—lung cancer	1.03e-07	1.32e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MAPK3—lung cancer	1.02e-07	1.31e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EP300—lung cancer	1.02e-07	1.31e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—lung cancer	1.02e-07	1.31e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—lung cancer	1.02e-07	1.31e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—lung cancer	1.02e-07	1.31e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—lung cancer	1.01e-07	1.3e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—lung cancer	1.01e-07	1.29e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NRAS—lung cancer	1.01e-07	1.29e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—lung cancer	1e-07	1.29e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—lung cancer	1e-07	1.29e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—lung cancer	1e-07	1.29e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—HRAS—lung cancer	1e-07	1.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NRAS—lung cancer	1e-07	1.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—lung cancer	1e-07	1.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—lung cancer	9.99e-08	1.28e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—KRAS—lung cancer	9.99e-08	1.28e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MAPK3—lung cancer	9.99e-08	1.28e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—HRAS—lung cancer	9.98e-08	1.28e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PIK3CA—lung cancer	9.97e-08	1.28e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—KRAS—lung cancer	9.96e-08	1.28e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MYC—lung cancer	9.95e-08	1.28e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TP53—lung cancer	9.93e-08	1.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SRC—lung cancer	9.93e-08	1.27e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—lung cancer	9.86e-08	1.26e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PIK3CA—lung cancer	9.84e-08	1.26e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—lung cancer	9.73e-08	1.25e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOA1—lung cancer	9.72e-08	1.25e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2E1—lung cancer	9.71e-08	1.25e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MYC—lung cancer	9.71e-08	1.25e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—lung cancer	9.67e-08	1.24e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PIK3CA—lung cancer	9.67e-08	1.24e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PIK3CA—lung cancer	9.67e-08	1.24e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TP53—lung cancer	9.64e-08	1.24e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MAPK3—lung cancer	9.63e-08	1.23e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—lung cancer	9.62e-08	1.23e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NQO1—lung cancer	9.6e-08	1.23e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—lung cancer	9.59e-08	1.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—lung cancer	9.58e-08	1.23e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MAPK3—lung cancer	9.57e-08	1.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NRAS—lung cancer	9.55e-08	1.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—lung cancer	9.55e-08	1.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—lung cancer	9.54e-08	1.22e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TP53—lung cancer	9.52e-08	1.22e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—lung cancer	9.5e-08	1.22e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—HRAS—lung cancer	9.5e-08	1.22e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MYC—lung cancer	9.36e-08	1.2e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TP53—lung cancer	9.35e-08	1.2e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TP53—lung cancer	9.35e-08	1.2e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MYC—lung cancer	9.31e-08	1.19e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—lung cancer	9.27e-08	1.19e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—HRAS—lung cancer	9.22e-08	1.18e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—lung cancer	9.22e-08	1.18e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—KRAS—lung cancer	9.2e-08	1.18e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PIK3CA—lung cancer	9.18e-08	1.18e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—lung cancer	9.16e-08	1.17e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PIK3CA—lung cancer	9.15e-08	1.17e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MAPK3—lung cancer	9.15e-08	1.17e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—lung cancer	9.11e-08	1.17e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—HRAS—lung cancer	9.11e-08	1.17e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—lung cancer	9.09e-08	1.17e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CB—lung cancer	9.01e-08	1.16e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—KRAS—lung cancer	8.97e-08	1.15e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—HRAS—lung cancer	8.94e-08	1.15e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—HRAS—lung cancer	8.94e-08	1.15e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—lung cancer	8.93e-08	1.15e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MYC—lung cancer	8.9e-08	1.14e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TP53—lung cancer	8.88e-08	1.14e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CG—lung cancer	8.87e-08	1.14e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TP53—lung cancer	8.85e-08	1.14e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—lung cancer	8.84e-08	1.13e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—lung cancer	8.83e-08	1.13e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—lung cancer	8.81e-08	1.13e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—lung cancer	8.72e-08	1.12e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—lung cancer	8.7e-08	1.12e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—STK11—lung cancer	8.66e-08	1.11e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—KRAS—lung cancer	8.65e-08	1.11e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—KRAS—lung cancer	8.6e-08	1.1e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—lung cancer	8.56e-08	1.1e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—lung cancer	8.56e-08	1.1e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—HRAS—lung cancer	8.49e-08	1.09e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—HRAS—lung cancer	8.47e-08	1.09e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PIK3CA—lung cancer	8.45e-08	1.08e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—lung cancer	8.45e-08	1.08e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—lung cancer	8.39e-08	1.08e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PIK3CA—lung cancer	8.24e-08	1.06e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CREBBP—lung cancer	8.23e-08	1.06e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—KRAS—lung cancer	8.22e-08	1.05e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TP53—lung cancer	8.17e-08	1.05e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—lung cancer	8.14e-08	1.04e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—lung cancer	8.12e-08	1.04e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—lung cancer	8.1e-08	1.04e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—lung cancer	8.04e-08	1.03e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTP1—lung cancer	8.01e-08	1.03e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TP53—lung cancer	7.98e-08	1.02e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PIK3CA—lung cancer	7.95e-08	1.02e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PIK3CA—lung cancer	7.9e-08	1.01e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—lung cancer	7.9e-08	1.01e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—lung cancer	7.9e-08	1.01e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—HRAS—lung cancer	7.82e-08	1e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CD—lung cancer	7.8e-08	1e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAT—lung cancer	7.8e-08	1e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTEN—lung cancer	7.79e-08	9.99e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—lung cancer	7.7e-08	9.88e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TP53—lung cancer	7.69e-08	9.86e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PIK3CA—lung cancer	7.67e-08	9.83e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TP53—lung cancer	7.65e-08	9.81e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—HRAS—lung cancer	7.63e-08	9.78e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PIK3CA—lung cancer	7.6e-08	9.75e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ABCB1—lung cancer	7.58e-08	9.73e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PIK3CA—lung cancer	7.55e-08	9.69e-07	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—lung cancer	7.5e-08	9.61e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—lung cancer	7.48e-08	9.6e-07	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—lung cancer	7.48e-08	9.59e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TYMS—lung cancer	7.45e-08	9.55e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—EP300—lung cancer	7.42e-08	9.52e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—lung cancer	7.36e-08	9.44e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—HRAS—lung cancer	7.35e-08	9.43e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—HRAS—lung cancer	7.31e-08	9.38e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TP53—lung cancer	7.31e-08	9.37e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—lung cancer	7.3e-08	9.36e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—lung cancer	7.04e-08	9.03e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—lung cancer	7e-08	8.98e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—HRAS—lung cancer	6.99e-08	8.96e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1A1—lung cancer	6.98e-08	8.95e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ERCC2—lung cancer	6.92e-08	8.88e-07	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—lung cancer	6.9e-08	8.85e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CB—lung cancer	6.8e-08	8.72e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—lung cancer	6.74e-08	8.64e-07	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—lung cancer	6.74e-08	8.64e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—lung cancer	6.69e-08	8.58e-07	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—lung cancer	6.49e-08	8.33e-07	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—lung cancer	6.46e-08	8.28e-07	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—lung cancer	6.26e-08	8.03e-07	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—lung cancer	6.21e-08	7.96e-07	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—lung cancer	6.17e-08	7.92e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOA1—lung cancer	5.99e-08	7.68e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTEN—lung cancer	5.87e-08	7.54e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—EP300—lung cancer	5.6e-08	7.19e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3CA—lung cancer	5.49e-08	7.04e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CG—lung cancer	5.47e-08	7.01e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—lung cancer	5.2e-08	6.67e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CREBBP—lung cancer	5.07e-08	6.5e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CD—lung cancer	4.81e-08	6.16e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—lung cancer	4.74e-08	6.08e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—lung cancer	4.49e-08	5.75e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CB—lung cancer	4.19e-08	5.37e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—lung cancer	4.15e-08	5.32e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3CA—lung cancer	4.14e-08	5.32e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTEN—lung cancer	3.62e-08	4.64e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—EP300—lung cancer	3.45e-08	4.43e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—lung cancer	3.39e-08	4.34e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3CA—lung cancer	2.55e-08	3.28e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—lung cancer	2.09e-08	2.68e-07	CbGpPWpGaD
